Global and North America Oncology Biosimilars Market Status and Future Forecast 2013-2023

May 2018 | 71 pages | ID: GF7CB41D11EEN
99Strategy

Abstracts

SUMMARY

Key Content of Chapters (Including and can be customized)

Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Region
Part 3:
North America Market by company, Type, Application & Region
Part 4-6:
Key Regions of North America Market by Type, Application
Part 7:
Company information, Sales, Cost, Margin etc.
Part 8:
Conclusion

Market Segment as follows:

By Region

• Global (North America, Europe, Asia etc.)
• North America (United States, Canada, Mexico)

Key Companies

• Celltrion Inc.
• Pfizer Inc.
• Biocon
• BIOCAD
• Apotex Inc.
• Dr. Reddy's
• Sandoz International GmbH
• Intas Pharmaceuticals Ltd.
• STADA Arzneimittel AG
• Teva Pharmaceutical Industries Ltd

Market by Type

• G-CSF
• Hematopoietic Agents
• Monoclonal Antibodies

Market by Application

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

3.1 North America Market by Region
3.2 North America Market by Company
3.3 North America Market by Type
3.4 North America Market by Application
3.5 North America Market by Forecast

PART 4 UNITED STATES MARKET STATUS AND FUTURE FORECAST

4.1 United States Market by Type
4.2 United States Market by Application
4.3 United States Market by Forecast

PART 5 CANADA MARKET STATUS AND FUTURE FORECAST

5.1 Canada Market by Type
5.2 Canada Market by Application
5.3 Canada Market by Forecast

PART 6 MEXICO MARKET STATUS AND FUTURE FORECAST

6.1 Mexico Market by Type
6.2 Mexico Market by Application
6.3 Mexico Market by Forecast

PART 7 KEY COMPANIES

7.1 Celltrion Inc.
7.2 Pfizer Inc.
7.3 Biocon
7.4 BIOCAD
7.5 Apotex Inc.
7.6 Dr. Reddy's
7.7 Sandoz International GmbH
7.8 Intas Pharmaceuticals Ltd.
7.9 STADA Arzneimittel AG
7.10 Teva Pharmaceutical Industries Ltd

PART 8 CONCLUSION

List Of Tables

LIST OF TABLES

Table Type of Oncology Biosimilars
Table Application of Oncology Biosimilars
Table Global Oncology Biosimilars Market by Region, 2013-2017 (Million USD)
Table Global Oncology Biosimilars Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Oncology Biosimilars Market by Company, 2013-2017 (Million USD)
Table Global Oncology Biosimilars Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Oncology Biosimilars Market by Type, 2013-2017 (Million USD)
Table Global Oncology Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Oncology Biosimilars Market by Application, 2013-2017 (Million USD)
Table Global Oncology Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table North America Oncology Biosimilars Market by Region, 2013-2017 (Million USD)
Table North America Oncology Biosimilars Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table North America Oncology Biosimilars Market by Company, 2013-2017 (Million USD)
Table North America Oncology Biosimilars Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table North America Oncology Biosimilars Market by Type, 2013-2017 (Million USD)
Table North America Oncology Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table North America Oncology Biosimilars Market by Application, 2013-2017 (Million USD)
Table North America Oncology Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table United States Oncology Biosimilars Market by Type, 2013-2017 (Million USD)
Table United States Oncology Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table United States Oncology Biosimilars Market by Application, 2013-2017 (Million USD)
Table United States Oncology Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Canada Oncology Biosimilars Market by Type, 2013-2017 (Million USD)
Table Canada Oncology Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Canada Oncology Biosimilars Market by Application, 2013-2017 (Million USD)
Table Canada Oncology Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Mexico Oncology Biosimilars Market by Type, 2013-2017 (Million USD)
Table Mexico Oncology Biosimilars Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Mexico Oncology Biosimilars Market by Application, 2013-2017 (Million USD)
Table Mexico Oncology Biosimilars Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Celltrion Inc. Information
Table Oncology Biosimilars Sales, Cost, Margin of Celltrion Inc.
Table Pfizer Inc. Information
Table Oncology Biosimilars Sales, Cost, Margin of Pfizer Inc.
Table Biocon Information
Table Oncology Biosimilars Sales, Cost, Margin of Biocon
Table BIOCAD Information
Table Oncology Biosimilars Sales, Cost, Margin of BIOCAD
Table Apotex Inc. Information
Table Oncology Biosimilars Sales, Cost, Margin of Apotex Inc.
Table Dr. Reddy's Information
Table Oncology Biosimilars Sales, Cost, Margin of Dr. Reddy's
Table Sandoz International GmbH Information
Table Oncology Biosimilars Sales, Cost, Margin of Sandoz International GmbH
Table Intas Pharmaceuticals Ltd. Information
Table Oncology Biosimilars Sales, Cost, Margin of Intas Pharmaceuticals Ltd.
Table STADA Arzneimittel AG Information
Table Oncology Biosimilars Sales, Cost, Margin of STADA Arzneimittel AG
Table Teva Pharmaceutical Industries Ltd Information
Table Oncology Biosimilars Sales, Cost, Margin of Teva Pharmaceutical Industries Ltd

List Of Figures

LIST OF FIGURES

Figure Global Oncology Biosimilars Market Share by Type in 2018
Figure Global Oncology Biosimilars Market Share by Application in 2018
Figure Global Oncology Biosimilars Market Share by Region in 2018
Figure North America Oncology Biosimilars Market Share by Region in 2018
Figure Global Oncology Biosimilars Market Share by Region in 2017 (Million USD)
Figure Global Oncology Biosimilars Market Share by Region in 2017 (Volume)
Figure Global Oncology Biosimilars Market Share by Company in 2017 (Million USD)
Figure Global Oncology Biosimilars Market Share by Company in 2017 (Volume)
Figure Global Oncology Biosimilars Market Share by Type in 2017 (Million USD)
Figure Global Oncology Biosimilars Market Share by Type in 2017 (Volume)
Figure Global Oncology Biosimilars Market Share by Application in 2017 (Million USD)
Figure Global Oncology Biosimilars Market Share by Application in 2017 (Volume)
Figure Global Oncology Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Global Oncology Biosimilars Market Forecast, 2018-2023 (Volume)
Figure North America Oncology Biosimilars Market Share by Region in 2017 (Million USD)
Figure North America Oncology Biosimilars Market Share by Region in 2017 (Volume)
Figure North America Oncology Biosimilars Market Share by Company in 2017 (Million USD)
Figure North America Oncology Biosimilars Market Share by Company in 2017 (Volume)
Figure North America Oncology Biosimilars Market Share by Type in 2017 (Million USD)
Figure North America Oncology Biosimilars Market Share by Type in 2017 (Volume)
Figure North America Oncology Biosimilars Market Share by Application in 2017 (Million USD)
Figure North America Oncology Biosimilars Market Share by Application in 2017 (Volume)
Figure North America Oncology Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure North America Oncology Biosimilars Market Forecast, 2018-2023 (Volume)
Figure United States Oncology Biosimilars Market Share by Type in 2017 (Million USD)
Figure United States Oncology Biosimilars Market Share by Type in 2017 (Volume)
Figure United States Oncology Biosimilars Market Share by Application in 2017 (Million USD)
Figure United States Oncology Biosimilars Market Share by Application in 2017 (Volume)
Figure United States Oncology Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure United States Oncology Biosimilars Market Forecast, 2018-2023 (Volume)
Figure Canada Oncology Biosimilars Market Share by Type in 2017 (Million USD)
Figure Canada Oncology Biosimilars Market Share by Type in 2017 (Volume)
Figure Canada Oncology Biosimilars Market Share by Application in 2017 (Million USD)
Figure Canada Oncology Biosimilars Market Share by Application in 2017 (Volume)
Figure Canada Oncology Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Canada Oncology Biosimilars Market Forecast, 2018-2023 (Volume)
Figure Mexico Oncology Biosimilars Market Share by Type in 2017 (Million USD)
Figure Mexico Oncology Biosimilars Market Share by Type in 2017 (Volume)
Figure Mexico Oncology Biosimilars Market Share by Application in 2017 (Million USD)
Figure Mexico Oncology Biosimilars Market Share by Application in 2017 (Volume)
Figure Mexico Oncology Biosimilars Market Forecast, 2018-2023 (Million USD)
Figure Mexico Oncology Biosimilars Market Forecast, 2018-2023 (Volume)